233 Repolarizing M2 to M1 macrophages using chimeric antigen receptors (CAR) for solid tumors

• Rachel Morris,
• Michael Boyer,
• Michelle Townsend,
• Timothy Phares,
• Adam Blaszczak,
• Rachel Garlick,
• Kenneth Katschke,
• Gaju Shrestha,
• Ashlin Cowger,
• Taylor Brindley,
• McCall Jensen,
• Audrey Meade,
• Tony Mortimer,
• Kim O’Neill

Affiliations

Rachel Morris

Marie Curie Hospice Liverpool

Michael Boyer

Department of Medical Oncology, Chris O’Brien Lifehouse, Camperdown, New South Wales, Australia

Michelle Townsend

Thunder Biotech, Provo, UT, USA

Timothy Phares

Thunder Biotech, Provo, UT, USA

Adam Blaszczak

Thunder Biotech, Provo, UT, USA

Rachel Garlick

Thunder Biotech, Provo, UT, USA

Kenneth Katschke

Thunder Biotech, Provo, UT, USA

Gaju Shrestha

Thunder Biotech, Provo, UT, USA

Ashlin Cowger

Thunder Biotech, Provo, UT, USA

Taylor Brindley

Thunder Biotech, Provo, UT, USA

McCall Jensen

Thunder Biotech, Provo, UT, USA

Audrey Meade

Thunder Biotech, Provo, UT, USA

Tony Mortimer

Thunder Biotech, Provo, UT, USA

Kim O’Neill

Thunder Biotech, Provo, UT, USA